Dapagliflozin DELIVERs Regardless of BP in Preserved-EF HF Dapagliflozin DELIVERs Regardless of BP in Preserved-EF HF

The finding may alleviate long-standing concerns that starting modestly diuretic SGLT2 inhibitors in patients with HF might present a hazard to those with a low systolic BP, researchers say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news